Stock listing

OTC:ESMC Escalon Medical Corp. Stock

Follow Escalon Medical Corp. into a list and get an email when it puts out news.

Share price · OTC:ESMC

$0.23 USD +0.04 (+22.0%)

Close on Nov 20, 2026

Past year +43.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.225 – $0.23 USDNov 20, 2026
Volume
2,657 sharesNov 20, 2026
Market cap
$1.71M USDAt the close on Nov 20, 2026 · price × 7.42M shares outstanding
52-week range
$0.14 – $0.29 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1,814 USDMedian day 2,000 shares · 17 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Escalon Medical Corp. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:ESMC · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.23+0.042+22.0%$0.225$0.23$0.2252,657
$0.189+0.012+6.9%$0.19$0.19$0.18945,000
$0.176+0.006+3.8%$0.176$0.176$0.1762,200
$0.17-0.02-10.5%$0.17$0.17$0.1710,010
$0.190.000.0%$0.19$0.19$0.19500
$0.19+0.003+1.5%$0.187$0.19$0.18720,585
$0.1870.000.0%$0.187$0.187$0.18750
$0.187+0.012+7.0%$0.187$0.187$0.187500
$0.175-0.002-1.2%$0.175$0.175$0.17515,000
$0.177+0.007+4.2%$0.177$0.177$0.1775,200
$0.170.000.0%$0.17$0.17$0.171,213
$0.170.000.0%$0.17$0.17$0.170
$0.17-0.01-5.6%$0.17$0.17$0.172,000
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.180
$0.18+0.01+5.9%$0.18$0.18$0.185,800
$0.17-0.01-5.6%$0.17$0.18$0.1770,000
$0.180.000.0%$0.18$0.18$0.1750,600
$0.18+0.01+5.9%$0.16$0.18$0.1621,500
$0.17+0.02+13.3%$0.17$0.17$0.1630,100
$0.150.000.0%$0.15$0.15$0.15300
$0.150.000.0%$0.15$0.15$0.150
$0.15-0.01-6.3%$0.15$0.15$0.156,000
$0.16-0.02-11.1%$0.16$0.16$0.1627,500
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.180
$0.18+0.01+5.9%$0.17$0.18$0.1651,500
$0.170.000.0%$0.17$0.17$0.17800
$0.170.000.0%$0.17$0.17$0.171,300
$0.170.000.0%$0.17$0.17$0.170
$0.170.000.0%$0.17$0.17$0.170
$0.17-0.02-10.5%$0.18$0.18$0.171,100
$0.19+0.03+18.8%$0.17$0.19$0.1749,500
$0.160.000.0%$0.16$0.16$0.160
$0.160.000.0%$0.16$0.16$0.160
$0.160.000.0%$0.16$0.16$0.160
$0.160.000.0%$0.16$0.16$0.16200
$0.160.000.0%$0.16$0.16$0.160
$0.160.000.0%$0.16$0.16$0.1610,000
$0.16-0.01-5.9%$0.15$0.16$0.1527,500
$0.170.000.0%$0.17$0.17$0.170
$0.170.000.0%$0.17$0.17$0.1728,400
$0.170.000.0%$0.17$0.17$0.172,600
$0.170.000.0%$0.17$0.17$0.17500
$0.17+0.005+3.0%$0.17$0.17$0.173,500
$0.165-0.01-5.7%$0.165$0.165$0.1653,082
$0.175+0.004+2.1%$0.171$0.175$0.1711,250
$0.171-0.019-9.8%$0.165$0.171$0.1653,332
$0.19+0.02+11.8%$0.17$0.19$0.174,000
$0.17-0.01-5.6%$0.18$0.18$0.1740,400
$0.180.000.0%$0.18$0.18$0.180
$0.180.000.0%$0.18$0.18$0.185,100
$0.180.000.0%$0.18$0.18$0.1826,500
$0.180.000.0%$0.18$0.18$0.180
$0.18+0.01+5.9%$0.18$0.18$0.1810,000

Splits

2 splits since 1993 · OTC:ESMC · every price before a split is adjusted for it

DayRatioWhat
1-for-4Consolidation
2-for-5Consolidation
Ticker
OTC:ESMC
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
OTC
Currency
USD

Escalon Medical Corp. on 6ix

Sector
Health care
Industry
Medical devices & supplies

Valuation

P/E 0.4× against a median of 8.5×: the lowest of 3 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$1.96M USD
P/E
0.4×
EV/sales
−0.1×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
0.3×
Gross margin
44.1%
Operating margin
3.8%
Net margin
32.8%
Debt to equity
0.0×
Beta vs S&P 500
-0.06

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Escalon Medical Corp. · OTC:ESMCUS$1.71M−US$1.96M0.4×−0.1×n/a0.3×32.8%0.0×-0.06
RemSleep Holdings, Inc. · OTC:RMSLUS$2.09MUS$2.06Mn/a123×n/an/an/an/a-0.01
Fuse Medical, Inc. · OTC:FZMDUS$2.03MUS$4.31M14.8×0.5×7.8×0.3×1.5%0.4×0.54
Nuwellis, Inc. · NASDAQ:NUWEUS$1.84M−US$6.31Mn/a−0.7×n/a0.2×−152.8%0.0×2.26
Vivos Therapeutics, Inc. · NASDAQ:VVOSUS$1.83MUS$2.11Mn/a0.1×n/a0.8×−107.1%0.2×1.41
Autonomix Medical, Inc. · NASDAQ:AMIXUS$1.82M−US$5.87Mn/an/an/a0.3×n/a0.0×1.79
Adagio Medical Holdings, Inc · NASDAQ:ADGMUS$1.72MUS$636,0102.1×n/an/a0.1×n/a0.1×0.69
Therma Bright Inc. · TSXV:THRMUS$1.66MUS$1.64Mn/a17.3×n/an/an/an/a-0.15
Nexalin Technology, Inc. · NASDAQ:NXLUS$1.45MUS$1.88Mn/a6.8×n/a5.5×n/a4.7×0.52
Zero Candida Technologies Inc. · TSXV:ZCTUS$1.43M−US$59,297n/an/an/a2.2×n/a0.0×-0.17
Osteopore Ltd. · ASX:OSXUS$1.38MUS$596,079n/a0.3×n/an/a−121.8%n/an/a
Median of the othersUS$1.77MUS$1.14M8.5×0.5×7.8×0.3×−114.5%0.1×0.54

Team and board

Officers

OfficerRole
Richard J. DePianoBoard Chairman, CEO, President, General Counsel
Mark G. WallaceCOO and Principal Financial and Accounting Officer

Board

DirectorRole
C. Todd TruskDirector
David JacoviniDirector
John P. DogumDirector
Lisa NapolitanoDirector

Events

QuarterResultsShare move
Q4 2025Sep 29, 2025−43.3%
Q3 2025May 14, 2025+110.5%
Q2 2025Feb 19, 2025+11.8%
Q1 2025Nov 18, 20240.0%
Q4 2024Sep 23, 2024−20.0%
Q3 2024May 10, 2024
Q2 2024Feb 21, 2024
Q1 2024Nov 15, 2023+1.7%
Q4 2023Sep 25, 20230.0%
Q3 2023May 12, 2023+16.7%
All 19 quarters
QuarterResultsShare move
Q2 2023Feb 15, 2023+4.0%
Q1 2023Nov 16, 2022−16.6%
Q4 2022Sep 19, 2022−8.4%
Q3 2022May 13, 2022
Q2 2022Feb 16, 2022+3.5%
Quarter to Sep 30, 2021Nov 10, 2021−19.5%
Quarter to Jun 30, 2021Sep 20, 2021+0.6%
Quarter to Mar 31, 2021May 7, 2021+7.2%
Quarter to Dec 31, 2020Feb 17, 2021+37.4%

Open Events

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue12.7M12.0M12.0M12.2M10.7M10.5M9.40M9.63M11.4M11.2M
Cost of revenue7.17M6.54M6.84M6.70M6.10M6.04M5.20M5.00M6.30M6.08M
Gross profit5.57M5.51M5.15M5.48M4.61M4.43M4.20M4.63M5.10M5.15M
Research and development501.5K753.1K688.2K818.8K991.0K890.5K1.12M739.8K500.3K1.05M
Selling, general and administrative5.02M4.62M4.56M4.18M4.09M3.57M3.87M4.14M4.40M4.60M
Operating income45.2K133.2K-104.5K478.5K-470.1K-33.7K-1.40M-253.0K204.7K-626.9K
Depreciation and amortization22.6K37.8K46.0K45.2K48.4K44.8K50.1K50.1K49.2K45.9K
EBITDA67.8K171.0K-58.5K523.7K-421.6K11.1K-1.35M-202.8K253.9K-581.0K
Interest expense7.46K22.7K20.8K21.7K18.4K21.8K13.6K17.4K125.7K100.3K
Income before tax2.87M105.5K
Income tax-1.14M0000
Net income4.01M105.5K-125.3K456.8K18.1K-52.0K-650.3K-250.0K583.7K-726.9K
Earnings per share, basic0.270.00-0.020.030.00-0.01-0.09-0.040.07-0.10
Earnings per share, diluted0.270.00-0.020.030.00-0.01-0.09-0.040.06-0.10

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents3.07M545.8K209.0K889.7K593.9K1.65M826.0K409.7K409.7K544.1K
Receivables1.90M1.50M2.12M1.65M1.54M1.08M1.31M1.50M1.39M1.48M
Inventory1.73M2.14M1.61M1.59M1.60M1.42M1.79M1.88M1.82M1.92M
Current assets7.01M4.61M4.40M4.64M4.19M4.59M4.33M4.26M4.58M4.16M
Property, plant and equipment26.6K34.6K48.9K34.1K52.7K81.4K97.2K67.9K76.3K54.9K
Goodwill0
Total assets9.13M4.99M4.76M5.31M5.17M5.68M5.72M5.13M5.43M4.98M
Accounts payable928.6K1.39M1.36M1.21M1.01M1.10M760.6K666.5K528.8K1.05M
Current liabilities2.39M2.69M2.67M2.85M3.00M3.40M2.87M2.26M2.25M3.00M
Long-term debt0
Total debt250.0K
Total liabilities3.20M3.08M2.95M3.37M3.69M4.22M4.21M2.97M3.01M3.80M
Shareholders' equity5.93M1.92M1.81M1.93M1.48M1.46M1.51M2.16M2.41M1.18M
Shares outstanding7.42M7.42M7.42M7.42M7.42M7.42M7.42M7.42M7.42M7.53M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-402.6K380.7K-602.8K325.1K-1.05M838.7K-168.5K-472.7K106.7K-506.0K
Capital spending-4.42K-3.88K-40.3K-6.69K0-9.39K-59.8K-22.1K-29.4K0
Free cash flow-407.0K376.8K-643.1K318.5K-1.05M829.3K-228.2K-494.8K77.4K-506.0K
Cash from investing2.80M-3.88K-40.3K-13.8K0-9.39K-59.8K-22.1K458.1K-8.00K
Cash from financing-129.9K-39.9K-37.5K-15.4K-6.93K-3.66K646.6K33.7K15.0K520.0K
Change in cash2.26M336.9K-680.5K295.9K-1.06M825.7K418.4K-461.1K579.9K6.00K

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 16, 2026Quarterly reportSEC
10-K · Annual reportOct 13, 2026Annual reportSEC
NT 10-K · Late filing noticeSep 28, 2026Explanation requestSEC
10-Q · Quarterly reportMay 15, 2026Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeApr 9, 2026Big-stake noticeSEC
10-Q · Quarterly reportFeb 17, 2026Quarterly reportSEC
8-K · Current reportJan 29, 2026Acquisition or disposalSEC
10-Q · Quarterly reportNov 14, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 6, 2025Big-stake noticeSEC
10-K · Annual reportSep 29, 2025Annual reportSEC
Show 200 filings
FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedJul 8, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 23, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 23, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
8-K · Current reportApr 4, 2025Current reportSEC
10-Q · Quarterly reportFeb 14, 2025Quarterly reportSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
10-K · Annual reportSep 30, 2024Annual reportSEC
10-Q · Quarterly reportMay 14, 2024Quarterly reportSEC
10-Q · Quarterly reportFeb 14, 2024Quarterly reportSEC
10-Q · Quarterly reportNov 17, 2023Quarterly reportSEC
NT 10-Q · Late filing noticeNov 15, 2023Explanation requestSEC
10-K · Annual reportOct 13, 2023Annual reportSEC
NT 10-K · Late filing noticeSep 29, 2023Explanation requestSEC
10-Q · Quarterly reportMay 15, 2023Quarterly reportSEC
10-Q · Quarterly reportFeb 14, 2023Quarterly reportSEC
10-Q · Quarterly reportNov 14, 2022Quarterly reportSEC
8-K · Current reportNov 2, 2022Current reportSEC
10-K · Annual reportSep 28, 2022Annual reportSEC
10-Q · Quarterly reportMay 13, 2022Quarterly reportSEC
10-Q · Quarterly reportFeb 14, 2022Quarterly reportSEC
10-Q · Quarterly reportNov 15, 2021Quarterly reportSEC
10-K/A · Annual report, amendedOct 22, 2021Annual reportSEC
10-K · Annual reportSep 27, 2021Annual reportSEC
10-Q · Quarterly reportMay 14, 2021Quarterly reportSEC
10-Q · Quarterly reportFeb 16, 2021Quarterly reportSEC
10-Q · Quarterly reportNov 16, 2020Quarterly reportSEC
10-K/A · Annual report, amendedOct 26, 2020Annual reportSEC
10-K · Annual reportSep 28, 2020Annual reportSEC
10-Q · Quarterly reportMay 14, 2020Quarterly reportSEC
10-Q · Quarterly reportFeb 14, 2020Quarterly reportSEC
10-Q · Quarterly reportNov 14, 2019Quarterly reportSEC
10-K/A · Annual report, amendedOct 25, 2019Annual reportSEC
10-K · Annual reportSep 27, 2019Annual reportSEC
10-Q · Quarterly reportMay 14, 2019Quarterly reportSEC
10-Q · Quarterly reportFeb 14, 2019Quarterly reportSEC
10-Q · Quarterly reportNov 14, 2018Quarterly reportSEC
10-K/A · Annual report, amendedOct 26, 2018Annual reportSEC
SC 13D · Big-stake noticeOct 23, 2018Big-stake noticeSEC
10-K · Annual reportSep 28, 2018Annual reportSEC
8-K · Current reportJul 6, 2018Material contractSEC
10-Q · Quarterly reportMay 14, 2018Quarterly reportSEC
3 · Initial statement of ownershipFeb 22, 2018Insider tradeSEC
3 · Initial statement of ownershipFeb 21, 2018Insider tradeSEC
8-K · Current reportFeb 20, 2018Management or board changeSEC
4 · Change in ownershipFeb 16, 2018Insider tradeSEC
8-K · Current reportFeb 14, 2018Material contractSEC
10-Q · Quarterly reportFeb 14, 2018Quarterly reportSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2018Big-stake noticeSEC
8-K · Current reportJan 24, 2018Current reportSEC
10-Q · Quarterly reportNov 14, 2017Quarterly reportSEC
10-K/A · Annual report, amendedOct 27, 2017Annual reportSEC
10-K · Annual reportSep 28, 2017Annual reportSEC
8-K · Current reportJul 7, 2017Management or board changeSEC
8-K · Current reportJul 6, 2017Meeting outcomeSEC
DEF 14A · Proxy statementMay 18, 2017Meeting noticeSEC
DEFA14A · Additional proxy materialMay 18, 2017Meeting noticeSEC
ARS · Annual report to shareholdersMay 18, 2017Annual reportSEC
10-Q · Quarterly reportMay 15, 2017Quarterly reportSEC
10-Q · Quarterly reportFeb 14, 2017Quarterly reportSEC
SC 13G/A · Big-stake notice, amendedFeb 10, 2017Big-stake noticeSEC
25-NSEJan 25, 2017Other filingsSEC
8-K · Current reportJan 5, 2017Material contractSEC
SC 13G/A · Big-stake notice, amendedNov 30, 2016Big-stake noticeSEC
10-Q · Quarterly reportNov 18, 2016Quarterly reportSEC
8-K · Current reportNov 16, 2016Current reportSEC
NT 10-Q · Late filing noticeNov 15, 2016Explanation requestSEC
10-K/A · Annual report, amendedNov 1, 2016Annual reportSEC
10-K · Annual reportOct 12, 2016Annual reportSEC
NT 10-K · Late filing noticeSep 29, 2016Explanation requestSEC
8-K · Current reportSep 6, 2016Current reportSEC
8-K · Current reportAug 19, 2016Current reportSEC
10-Q · Quarterly reportMay 16, 2016Quarterly reportSEC
4 · Change in ownershipMay 16, 2016Insider tradeSEC
4 · Change in ownershipMay 16, 2016Insider tradeSEC
4 · Change in ownershipMay 16, 2016Insider tradeSEC
4 · Change in ownershipMay 16, 2016Insider tradeSEC
8-K · Current reportMar 7, 2016Current reportSEC
8-K · Current reportFeb 23, 2016Current reportSEC
10-Q · Quarterly reportFeb 16, 2016Quarterly reportSEC
SC 13G · Big-stake noticeFeb 12, 2016Big-stake noticeSEC
8-K · Current reportJan 5, 2016Meeting outcomeSEC
DEF 14A · Proxy statementNov 19, 2015Meeting noticeSEC
DEFA14A · Additional proxy materialNov 19, 2015Meeting noticeSEC
ARS · Annual report to shareholdersNov 19, 2015Annual reportSEC
10-Q · Quarterly reportNov 16, 2015Quarterly reportSEC
3 · Initial statement of ownershipNov 13, 2015Insider tradeSEC
8-K · Current reportOct 29, 2015Management or board changeSEC
10-K/A · Annual report, amendedOct 28, 2015Annual reportSEC
8-K · Current reportSep 30, 2015Management or board changeSEC
10-K/A · Annual report, amendedSep 29, 2015Annual reportSEC
10-K · Annual reportSep 28, 2015Annual reportSEC
10-Q · Quarterly reportMay 14, 2015Quarterly reportSEC
10-Q · Quarterly reportFeb 13, 2015Quarterly reportSEC
8-K · Current reportDec 31, 2014Meeting outcomeSEC
DEFA14A · Additional proxy materialNov 17, 2014Meeting noticeSEC
10-Q · Quarterly reportNov 14, 2014Quarterly reportSEC
DEF 14A · Proxy statementNov 13, 2014Meeting noticeSEC
DEFA14A · Additional proxy materialNov 13, 2014Meeting noticeSEC
ARS · Annual report to shareholdersNov 13, 2014Annual reportSEC
10-K/A · Annual report, amendedOct 28, 2014Annual reportSEC
10-K · Annual reportSep 26, 2014Annual reportSEC
10-Q · Quarterly reportMay 14, 2014Quarterly reportSEC
4 · Change in ownershipMay 12, 2014Insider tradeSEC
4 · Change in ownershipMay 12, 2014Insider tradeSEC
4 · Change in ownershipMay 12, 2014Insider tradeSEC
4 · Change in ownershipMay 12, 2014Insider tradeSEC
4 · Change in ownershipMay 12, 2014Insider tradeSEC
4 · Change in ownershipMay 12, 2014Insider tradeSEC
4 · Change in ownershipMay 12, 2014Insider tradeSEC
4 · Change in ownershipMay 12, 2014Insider tradeSEC
10-Q · Quarterly reportFeb 14, 2014Quarterly reportSEC
8-K · Current reportJan 3, 2014Material contractSEC
ARS · Annual report to shareholdersNov 14, 2013Annual reportSEC
DEFA14A · Additional proxy materialNov 14, 2013Meeting noticeSEC
DEF 14A · Proxy statementNov 14, 2013Meeting noticeSEC
10-Q · Quarterly reportNov 12, 2013Quarterly reportSEC
10-K/A · Annual report, amendedOct 28, 2013Annual reportSEC
8-K · Current reportSep 25, 2013Management or board changeSEC
10-K · Annual reportSep 20, 2013Annual reportSEC
8-K · Current reportJul 2, 2013Meeting outcomeSEC
3 · Initial statement of ownershipMay 24, 2013Insider tradeSEC
8-K · Current reportMay 22, 2013Management or board changeSEC
DEF 14A · Proxy statementMay 17, 2013Meeting noticeSEC
ARS · Annual report to shareholdersMay 17, 2013Annual reportSEC
DEFA14A · Additional proxy materialMay 17, 2013Meeting noticeSEC
8-K · Current reportMay 15, 2013Management or board changeSEC
10-Q · Quarterly reportMay 10, 2013Quarterly reportSEC
10-Q · Quarterly reportFeb 14, 2013Quarterly reportSEC
8-K · Current reportDec 28, 2012Current reportSEC
4 · Change in ownershipDec 21, 2012Insider tradeSEC
10-Q · Quarterly reportNov 14, 2012Quarterly reportSEC
10-K/A · Annual report, amendedOct 26, 2012Annual reportSEC
8-K · Current reportOct 18, 2012Current reportSEC
8-K · Current reportOct 10, 2012Acquisition or disposalSEC
10-K · Annual reportSep 26, 2012Annual reportSEC
8-K · Current reportAug 17, 2012Current reportSEC
8-K · Current reportJun 29, 2012Meeting outcomeSEC
ARS · Annual report to shareholdersMay 30, 2012Annual reportSEC
DEFA14A · Additional proxy materialMay 17, 2012Meeting noticeSEC
DEF 14A · Proxy statementMay 17, 2012Meeting noticeSEC
10-Q · Quarterly reportMay 15, 2012Quarterly reportSEC
8-K · Current reportFeb 22, 2012Current reportSEC
10-Q · Quarterly reportFeb 14, 2012Quarterly reportSEC
8-K · Current reportJan 20, 2012Current reportSEC
10-Q · Quarterly reportNov 14, 2011Quarterly reportSEC
10-K/A · Annual report, amendedOct 28, 2011Annual reportSEC
10-K · Annual reportSep 28, 2011Annual reportSEC
8-K · Current reportJul 7, 2011Meeting outcomeSEC
DEFA14A · Additional proxy materialMay 20, 2011Meeting noticeSEC
DEF 14A · Proxy statementMay 20, 2011Meeting noticeSEC
10-Q · Quarterly reportMay 16, 2011Quarterly reportSEC
UPLOAD · Letter from the SECMay 9, 2011Other filingsSEC
CORRESP · Letter to the SECMay 6, 2011Other filingsSEC
8-K · Current reportMay 6, 2011Material contractSEC
UPLOAD · Letter from the SECApr 26, 2011Other filingsSEC
CORRESP · Letter to the SECApr 13, 2011Other filingsSEC
UPLOAD · Letter from the SECMar 23, 2011Other filingsSEC
10-Q · Quarterly reportFeb 11, 2011Quarterly reportSEC
10-Q · Quarterly reportNov 15, 2010Quarterly reportSEC
10-K/A · Annual report, amendedOct 28, 2010Annual reportSEC
10-K · Annual reportOct 12, 2010Annual reportSEC
NT 10-K · Late filing noticeSep 29, 2010Explanation requestSEC
8-K · Current reportSep 28, 2010ResultsSEC
8-K · Current reportJul 7, 2010Meeting outcomeSEC
DEF 14A · Proxy statementJun 16, 2010Meeting noticeSEC
10-Q · Quarterly reportMay 20, 2010Quarterly reportSEC
NT 10-Q · Late filing noticeMay 18, 2010Explanation requestSEC
8-K · Current reportMay 6, 2010Acquisition or disposalSEC
10-Q · Quarterly reportFeb 22, 2010Quarterly reportSEC
NT 10-Q/A · Late filing notice, amendedFeb 17, 2010Explanation requestSEC
NT 10-Q · Late filing noticeFeb 17, 2010Explanation requestSEC
4 · Change in ownershipNov 18, 2009Insider tradeSEC
4 · Change in ownershipNov 18, 2009Insider tradeSEC
4 · Change in ownershipNov 18, 2009Insider tradeSEC
4 · Change in ownershipNov 18, 2009Insider tradeSEC
10-Q · Quarterly reportNov 16, 2009Quarterly reportSEC
10-K/A · Annual report, amendedOct 28, 2009Annual reportSEC
10-K · Annual reportOct 13, 2009Annual reportSEC
NT 10-K · Late filing noticeSep 29, 2009Explanation requestSEC
DEF 14A · Proxy statementJun 12, 2009Meeting noticeSEC
EFFECT · Notice that a registration is effectiveMay 26, 2009Other filingsSEC
CORRESP · Letter to the SECMay 20, 2009Other filingsSEC
CORRESP · Letter to the SECMay 20, 2009Other filingsSEC
CORRESP · Letter to the SECMay 19, 2009Other filingsSEC
S-3/A · Registration statement, amendedMay 19, 2009Offer documentSEC
10-Q · Quarterly reportMay 15, 2009Quarterly reportSEC
UPLOAD · Letter from the SECMay 4, 2009Other filingsSEC
CORRESP · Letter to the SECApr 17, 2009Other filingsSEC
UPLOAD · Letter from the SECApr 9, 2009Other filingsSEC

This page holds 200 of 466 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Escalon Medical Corp.’s releases · as of Sep 25, 2026

Common shares
7,415,329
Fully diluted
7,415,329

Fully diluted

LineSharesAs of
Common shares7,415,329Sep 25, 2026

Share count over time

CountShares
Sep 25, 20267,415,329

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Fred G. Choate
Other companies: Parke Bancorp, Inc. (Director · Since at least Jun 12, 2015)
Director · Dec 3, 2007 – May 8, 2014 · Past
Anthony J CoppolaDirector · Dec 3, 2007 – Sep 29, 2008 · Past
Berkowitz DavidPrincipal Accounting Officer · Mar 3, 2006 – Mar 3, 2006 · Past
C. Todd TruskDirector · Nov 13, 2015 – May 12, 2016 · Past
John P. DogumDirector · Feb 13, 2017 – Feb 13, 2017 · Past
Richard J. DePianoDirector · May 12, 2016 – Feb 14, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about Escalon Medical Corp.